Xiaocong Xiang

Nanchong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Targeting Tex10 Overcomes Oxaliplatin Resistance by Competitively Disrupting the Non-Canonical BAF Complex in Colorectal Cancer.

Targeting Tex10 Overcomes Oxaliplatin Resistance by Competitively Disrupting the Non-Canonical BAF Complex in Colorectal Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 26, 2026

Lasiodin sensitizes hepatocellular carcinoma cancer to sorafenib via SNARE complex disruption.

Lasiodin sensitizes hepatocellular carcinoma cancer to sorafenib via SNARE complex disruption.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 07, 2025

Atractylenolide I Inhibits the Growth of Esophageal Cancer Cells by Inhibiting the Wnt/β-Catenin Pathway.

Atractylenolide I Inhibits the Growth of Esophageal Cancer Cells by Inhibiting the Wnt/β-Catenin Pathway.

Journal: Anti-cancer agents in medicinal chemistry

Published: November 15, 2024

Integrative analysis of the role of the DPH gene family in hepatocellular carcinoma and expression validation.

Integrative analysis of the role of the DPH gene family in hepatocellular carcinoma and expression validation.

Journal: Translational cancer research

Published: January 22, 2024

Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.

Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.

Journal: Molecular carcinogenesis

Published: April 13, 2023

Inhibition of STX17-SNAP29-VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway.

Inhibition of STX17-SNAP29-VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway.

Journal: Biochemical pharmacology

Published: February 01, 2023

Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2-related factor 2-mediated reactive oxygen species increment.

Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2-related factor 2-mediated reactive oxygen species increment.

Journal: Basic & clinical pharmacology & toxicology

Published: June 16, 2022

NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma.

NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma.

Journal: Technology in cancer research & treatment

Published: September 14, 2021

Chaetocin: A review of its anticancer potentials and mechanisms.

Chaetocin: A review of its anticancer potentials and mechanisms.

Journal: European journal of pharmacology

Published: June 05, 2021

Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway.

Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway.

Journal: Biochemical pharmacology

Published: January 15, 2021

Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.

Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.

Journal: Oncology reports

Published: March 30, 2019

Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.

Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.

Journal: Cell cycle (Georgetown, Tex.)

Published: July 27, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026